UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis

Journal of Virology, 2010-07, Vol.84 (14), p.7396-7404

2010

Volltextzugriff (PDF)

Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages

Retrovirology, 2019-10, Vol.16 (1), p.29-29, Article 29

2019

Volltextzugriff (PDF)

Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing

Viruses, 2021-07, Vol.13 (7), p.1338

2021

Volltextzugriff (PDF)

5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2318-2325

2016

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 2 Capsid Protein Mutagenesis Reveals Amino Acid Residues Important for Virus Particle Assembly

Journal of molecular biology, 2022-10, Vol.434 (19), p.167753-167753, Article 167753

2022

Volltextzugriff (PDF)

Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2

Journal of molecular biology, 2022-01, Vol.434 (2), p.167355-167355, Article 167355

2022

Volltextzugriff (PDF)

Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen

Journal of molecular biology, 2021-09, Vol.433 (18), p.167111-167111, Article 167111

2021

Volltextzugriff (PDF)

Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis

Antiviral research, 2019-10, Vol.170, p.104540-104540, Article 104540

2019

Volltextzugriff (PDF)

Back to the future: revisiting HIV-1 lethal mutagenesis

Trends in microbiology (Regular ed.), 2013-02, Vol.21 (2), p.56-62

2013

Volltextzugriff (PDF)

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (21), p.6642-6646

2012

Volltextzugriff (PDF)

Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra

Journal of molecular biology, 2017-07, Vol.429 (15), p.2290-2307

2017

Volltextzugriff (PDF)

Concomitant Lethal Mutagenesis of Human Immunodeficiency Virus Type 1

Journal of molecular biology, 2012-06, Vol.419 (3-4), p.158-170

2012

Volltextzugriff (PDF)

Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector

Methods in molecular biology (Clifton, N.J.), 2016, Vol.1354, p.71

2016

Volltextzugriff (PDF)

5,6-Dihydro-5-aza-2′-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

Bioorganic & medicinal chemistry, 2013-11, Vol.21 (22), p.7222-7228

2013

Volltextzugriff (PDF)

Lack of mutational hot spots during decitabine-mediated HIV-1 mutagenesis

Antimicrobial agents and chemotherapy, 2015-11, Vol.59 (11), p.6834-6843

2015

Volltextzugriff (PDF)

Characterization of Permeability, Stability and Anti-HIV-1 Activity of Decitabine and Gemcitabine Divalerate Prodrugs

Antiviral chemistry & chemotherapy, 2014-12, Vol.23 (6), p.223-230

2014

Volltextzugriff (PDF)

HIV mutagenesis and the evolution of antiretroviral drug resistance

Drug resistance updates, 2002-12, Vol.5 (6), p.219-223

Mansky, Louis M.

2002

Volltextzugriff (PDF)

Drug resistance, virus fitness and HIV-1 mutagenesis

Current pharmaceutical design, 2004-12, Vol.10 (32), p.4065-4070

2004

Volltextzugriff (PDF)

Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication

Virology (New York, N.Y.), 2003-03, Vol.307 (1), p.116-121

Mansky, Louis M

2003

Volltextzugriff (PDF)

The Primary Nucleotide Sequence of the Bovine Leukemia Virus RNA Packaging Signal Can Influence Efficient RNA Packaging and Virus Replication

Virology (New York, N.Y.), 2002-09, Vol.301 (2), p.272-280

2002

Volltextzugriff (PDF)

Nucleoside reverse transcriptase inhibitors and HIV mutagenesis

Journal of antimicrobial chemotherapy, 2003-10, Vol.52 (4), p.547-550

2003

Volltextzugriff (PDF)

The bovine leukemia virus encapsidation signal is composed of RNA secondary structures

Journal of Virology, 1998-04, Vol.72 (4), p.3196-3204

1998

Volltextzugriff (PDF)

The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene

Virology (New York, N.Y.), 1996-08, Vol.222 (2), p.391-400

Mansky, L M

1996

Volltextzugriff (PDF)

HIV-1 mutagenesis during antiretroviral therapy: implications for successful drug treatment

Frontiers in bioscience, 2005-01, Vol.10 (1-3), p.743

2005

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaMutagenesis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis

Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages

Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing

5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine

Human Immunodeficiency Virus Type 2 Capsid Protein Mutagenesis Reveals Amino Acid Residues Important for Virus Particle Assembly

Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2

Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen

Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis

Back to the future: revisiting HIV-1 lethal mutagenesis

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra

Concomitant Lethal Mutagenesis of Human Immunodeficiency Virus Type 1

Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector

5,6-Dihydro-5-aza-2′-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

Lack of mutational hot spots during decitabine-mediated HIV-1 mutagenesis

Characterization of Permeability, Stability and Anti-HIV-1 Activity of Decitabine and Gemcitabine Divalerate Prodrugs

HIV mutagenesis and the evolution of antiretroviral drug resistance

Drug resistance, virus fitness and HIV-1 mutagenesis

Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication

The Primary Nucleotide Sequence of the Bovine Leukemia Virus RNA Packaging Signal Can Influence Efficient RNA Packaging and Virus Replication

Nucleoside reverse transcriptase inhibitors and HIV mutagenesis

The bovine leukemia virus encapsidation signal is composed of RNA secondary structures

The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene

HIV-1 mutagenesis during antiretroviral therapy: implications for successful drug treatment

Aktive Filter

Suchergebnisse filtern